Alemán OOF, Sosa PEM, Fuentes FMJ, Islas MCD

Language: Spanish
References: 29
Page: 30-33
PDF size: 229.30 Kb.

ABSTRACT

The cervical lymphadenitis caused by Mycobacterium bovis is an underdiagnosed disease in the adult rural population with risk factors associated with low socioeconomic status, a situation which is extremely important differentiation from other mycobacteria because of the particular drug resistance of each entity. M. bovis has proven natural resistance to pyrazinamide, so the specific determination of antimicrobial susceptibility is essential for the establishment of an effective treatment. The present case report shows a patient with Streptomycin-resistant M. bovis lymphadenopathy and supports the need for an early diagnosis to establish an effective treatment.

REFERENCES

1. Forrellad, M.A., Klepp, L.I., Gioffré, A., Sabio y García, J., Morbidoni, H.R., Santangelo, M.D.L. et al., “Virulence factors of the Mycobacterium tuberculosis complex”, Virulence, 2013, 4 (1): 3-66.

2. Brosch, R., Gordon, S.V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K. et al., “A new evolutionary scenario for the Mycobacterium tuberculosis complex”, Proc Natl Acad Sci USA, 2002, 99: 3684-3689.

3. World Health Organization, “Global Health Observatory Data: Tuberculosis”, World Health Organization, 2015 (http://www.who.int/gho/tb/en/).

4. Müller, B., Dürr, S., Alonso, S., Hattendorf, J., Laisse, C.J., Parsons, S.D. et al., “Zoonotic Mycobacterium bovis- induced tuberculosis in humans”, Emerg Infect Dis, 2013, 19 (6): 899-908.

5. Cicero, R., Olivera, H., Hernández-Solís, A., Ramírez-Casanova, E. y Escobar-Gutiérrez, A., “Frequency of Mycobacterium bovis as an etiologic agent in extrapulmonary tuberculosis in hiv-positive and negative Mexican patients”, Eur J Clin Microbiol Infect Dis, 2009, 28: 455-460.

6. Pérez-Guerrero, L., Milian-Suazo, F., Arriga-Díaz, C., Romero- Torres, C. y Escartin-Chávez, M., “Epidemiología molecular de las tuberculosis bovina y humana en una zona endémica de Querétaro, México”, Salud Pública Mex, 2008, 50: 286-291.

7. Centers for Disease Control and Prevention, “Human tuberculosis caused by Mycobacterium bovis —New York City, 2001-2004”, Morb Mortal Wkly Rep, 2005, 54: 605-608.

8. Rodwell, T.C., Moore, M., Moser, K.S., Brodine, S.K. y Strathdee, S.A., “Tuberculosis from Mycobacterium bovis in binational communities, United States”, Emerg Infect Dis, 2008, 14: 909-916.

9. Bartralot, R., Pujol, R.M., García-Patos, V., Sitjas, D., Martin- Casabona, N., Coll, P. et al., “Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts”, J Cutan Pathol, 2000, 27 (3), 124-129.

10. Scorpio, A. y Zhang, Y., “Mutations in pnca, a gene encoding pyrazinamidase/ nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus”, Nat Med, 1996, 2: 662e7.

11. Wedlock, D.N., Skinner, M.A., DeLisle, G.W. y Buddle, B.M., “Control of Mycobacterium bovis infections and the risk to human populations”, Microbes Infect, 2002, 4: 471-480.

12. Ryan, T.J., Livingstone, P.G., Ramsey, D.S., De Lisle, G.W., Nugent, G., Collins, D.M. y Buddle, B.M., “Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand”, Vet Microbiol, 2006, 112: 211-219.

13. Clifton-Hadley, R.S., Wilesmith, J.W., Richards, M.S., Upon, P. y Johnston, S., “The occurrence of Mycobacterium bovis infection in cattle in and around an area subset to extensive badger (Meles meles) control”, Epidemiol Infect, 1995, 114: 179-193.

14. De Lisle, G.W., Mackintosh, C.G. y Bengis, R.G., “Mycobacterium bovis in free-living and captive wildlife, including farmed deer”, Rev Sci Tech, 2001, 20: 86-111.

15. Davies, P.D., “Tuberculosis in humans and animals: are we a threat to each other?”, J R Soc Med, 99, 2006: 539-540.

16. Suzuki, Y., Matsuba, T. y Nakajima, C., “Zoonotic aspects of tuberculosis caused by Mycobacterium bovis”, Kekkaku, 2010, 85 (2): 79-86.

17. Gallivan, M., Shah, N. y Flood, J., “Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011”, Emerg Infect Dis, 2015, 21 (3): 435-443.

18. Milian, F., Sánchez, L.M., Toledo, P., Ramírez, C. y Santillán, M.A., “Descriptive study of human and bovine tuberculosis in Querétaro, Mexico”, Rev Latinoam Microbiol, 2000, 42: 9-13.

19. Joint Tuberculosis Committee of the British Thoracic Society, “Control and prevention of tuberculosis in the United Kingdom: code of practice 2000”, Thorax, 2000, 55 (11): 887-901.

20. Hlavsa, M.C., Moonan, P.K., Cowan, L.S., Navin, T.R., Kammerer, J.S., Morlock, G.P. et al., “Human tuberculosis due to Mycobacterium bovis in the United States, 1995- 2005”, Clin Infect Dis, 2008, 47 (2): 168-175.

21. Menon, K., Bem, C., Gouldesbrough, D. y Strachan, D.R., “A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UK”, J Laryngol Otol, 2007, 121 (4): 362-368.

22. Hughes, V.M., Skuce, R., Doig, C., Stevenson, K., Sharp, J.M. y Watt, B., “Analysis of multidrug-resistant Mycobacterium bovis from three clinical samples from Scotland”, Int J Tuberc Lung Dis, 2003, 7: 1191e8.

23. Rivero, A., Márquez, M., Santos, J., Pinedo, A., Sánchez, M.A., Esteve, A., Samper, S. y Martin, C., “High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain b”, Clin Infect Dis, 2001, 32: 159e61.

24. Gori, A., Marchetti, G., Catozzi, L., Nigro, C., Ferrario, G., Rossi, M.C., Degli Esposti, A., Orani, A. y Franzetti, F., “Molecular epidemiology characterization of a multidrug- resistant Mycobacterium bovis outbreak amongst hiv-positive patients”, aids, 1998, 12: 445e6.

25. Bruijnesteijn, E.S., Lindeboom, J.A., Prins, J.M., Peeters, M.F., Claas, E.C. y Kuijper, E.J., “Real-time pcr assay using fine-needle aspirates and tissue biopsy specimen for rapid diagnosis of mycobacterial lymphadenitis in children”, J Clin Microbiol, 2004, 42 (6): 2644-2650.

26. LoBue, P.A. y Moser, K.S., “Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, CA, US 1994-2003”, Mem. Inst. Oswaldo Cruz, 2004, 99 (7): 749-752.

27. Ammari, F., Ashraf, H., Kamal, I. y Ghariebeh, F., “Tuberculosis of the lymph glands of the neck: a limited role for surgery”, Otolaryngol Head Neck Surg, 2003, 128: 576-580.

28. National Institute for Health and Clinical Excellence, Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control, Londres, nice, 2006.

29. Harris, L., Modayil, P., Adam, J., Sharland, M., Heath, P., Planche, T. y Daya, H., “Cervicofacial ontuberculous Mycobacterium lymphadenitis in children: is surgery always necessary?”, Int J Pediatr Otorhinolaryngol, 2009, 73 (9): 1297-1301.